UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1.3 µm 28 Gb/s EMLs with hybrid waveguide structure for low-power-consumption CFP2 transceivers

2013 Optical Fiber Communication Conference and Exposition and the National Fiber Optic Engineers Conference (OFC/NFOEC), 2013, p.1-3

2013

Volltextzugriff (PDF)

1,3-ジカプリロイル-2-エイコサペンタエノイルグリセロールの酵素合成

日本油化学会誌, 2000, Vol.49 (8), p.845-845

2000

Volltextzugriff (PDF)

A 1.8-V operation RF CMOS transceiver for 2.4-GHz-band GFSK applications

IEEE journal of solid-state circuits, 2003-05, Vol.38 (5), p.817-825

2003

Volltextzugriff (PDF)

A 1.8-V operation RFCMOS transceiver for Bluetooth

2002 Symposium on VLSI Circuits. Digest of Technical Papers (Cat. No.02CH37302), 2002, p.230-233

2002

Volltextzugriff (PDF)

10-Gb/s 100-km SMF Transmission Using InP Mach-Zehnder Modulator Monolithically Integrated With Semiconductor Optical Amplifier

IEEE photonics technology letters, 2008-07, Vol.20 (13), p.1178-1180

2008

Volltextzugriff (PDF)

10-Gb/s 100-km SMF Transmission Using InP MachaZehnder Modulator Monolithically Integrated With Semiconductor Optical Amplifier

IEEE photonics technology letters, 2008-01, Vol.20 (13)

2008

Volltextzugriff (PDF)

10-Gbit/s, 200 km duobinary SMF transmission using a full C-band tunable DFB laser array co-packaged with InP Mach-Zehnder modulator

2008 IEEE 21st International Semiconductor Laser Conference, 2008, p.17-18

2008

Volltextzugriff (PDF)

10-Gbit/s optical duobinary transmission using lossless InP n-p-i-n Mach-Zehnder modulator with semiconductor optical amplifier

2008 20th International Conference on Indium Phosphide and Related Materials, 2008, p.1-4

2008

Volltextzugriff (PDF)

1027 KUPFFER IMAGE BY CONTRAST-ENHANCED US WITH SONAZOID IS USEFUL FOR EVALUATING HYPOVASCULAR LIVER NODULES DEPICTED AS HYPOINTENSE IN THE HEPATOBILIARY PHASE OF GD-EOB-DTPA-ENHANCED MRI

Journal of hepatology, 2011-03, Vol.54, p.S408-S408

2011

Volltextzugriff (PDF)

1037 PREDICTING FACTORS OF LOCAL RECURRENCE AFTER CURATIVE PERCUTANEOUS RADIOFRECUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2012-04, Vol.56, p.S406-S406

2012

Volltextzugriff (PDF)

1038 DECREASE OF PLASMA VEGF LEVEL WITHIN 2 MONTHS AFTER SORAFENIB ADMINISTRATION PREDICTS TREATMENT EFFICACY AND PROGNOSIS IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2012-04, Vol.56, p.S406-S406

2012

Volltextzugriff (PDF)

1041 OUTCOMES OF RADIOFREQUENCY ABLATION FOR HYPOVASCULAR HEPATOCELLULAR CARCINOMAS

Journal of hepatology, 2012-04, Vol.56, p.S407-S407

2012

Volltextzugriff (PDF)

1070 Regenerating islet-derived related protein 4 as candidate of a novel biomarker in castration-resistant prostate cancer patients

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e1070-e1070

2016

Volltextzugriff (PDF)

107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

111 - Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e164-e164

2018

Volltextzugriff (PDF)

1111PRisk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1151 Gemcitabine plus paclitaxel as third-line chemotherapy: A feasible option for metastatic urothelial carcinoma patients

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e1151-e1151

2016

Volltextzugriff (PDF)

1251 Evaluation of pharmacokinetics and safety profiles between S-1 granule and S-1 capsule in patients with solid tumors

European journal of cancer supplements, 2009, Vol.7 (2), p.136-136

2009

Volltextzugriff (PDF)

1252 POSTER First Report of the Safety, Tolerability, and Pharmacokinetics of Saracatinib (AZD0530) in Japanese Patients With Advanced Solid Tumours

European journal of cancer (1990), 2011, Vol.47, p.S160-S160

2011

Volltextzugriff (PDF)

127PA model based on a new inflammation-nutrition score and TNM stage for predicting overall survival of patients with colorectal cancer

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

13 POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND BENEFIT OF VIRAL ERADICATION BY PEG-INTERFRON/RIBAVIRIN TREATMENT

Journal of hepatology, 2008, Vol.48, p.S7-S8

2008

Volltextzugriff (PDF)

1347 A PROSPECTIVE STUDY ON THE CLINICAL IMPACT OF VIRAL ERADICATION AND IL-28B GENOTYPE ON PEG-INTERFERON AND RIBAVIRIN THERAPY AFTER CURATIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2011-03, Vol.54, p.S531-S532

2011

Volltextzugriff (PDF)

1419 POSTER Identification of a Protein Kinase Activity Based Biomarker Fingerprint to Predict Response to Sunitinib, Sorafenib and Pazopanib in Scirrhous Gastric Cancer Cell Lines

European journal of cancer (1990), 2011, Vol.47, p.S175-S175

2011

Volltextzugriff (PDF)

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

Pharmacogenetics (London), 2001-08, Vol.11 (6), p.545-550

2001

Volltextzugriff (PDF)

1451P Neoadjuvant and adjuvant pembrolizumab (pembro) + chemotherapy (chemo) for locally advanced gastric or gastroesophageal junction (G/GEJ) cancer: Patient-reported outcomes (PROs) from the phase III KEYNOTE-585 study

Annals of oncology, 2024-09, Vol.35, p.S901-S902

2024

Volltextzugriff (PDF)

1 – 25 von 2.195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.732)
Mit Volltextzugriff
(1.716)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.265)
Life Sciences & Biomedicine
(1.008)
Humans
(880)
Male
(624)
Female
(563)
Biological And Medical Sciences
(551)
Medical Sciences
(438)
Middle Aged
(400)
Adult
(365)
Animals
(308)
Aged
(281)
Physical Sciences
(225)
Neurosciences & Neurology
(197)
Oncology
(173)
Surgery
(145)
Pharmacology. Drug Treatments
(142)
Fundamental And Applied Biological Sciences. Psychology
(139)
Technology
(134)
Pharmacology & Pharmacy
(133)
Clinical Neurology
(132)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

1.3 µm 28 Gb/s EMLs with hybrid waveguide structure for low-power-consumption CFP2 transceivers

1,3-ジカプリロイル-2-エイコサペンタエノイルグリセロールの酵素合成

A 1.8-V operation RF CMOS transceiver for 2.4-GHz-band GFSK applications

A 1.8-V operation RFCMOS transceiver for Bluetooth

10-Gb/s 100-km SMF Transmission Using InP Mach-Zehnder Modulator Monolithically Integrated With Semiconductor Optical Amplifier

10-Gb/s 100-km SMF Transmission Using InP MachaZehnder Modulator Monolithically Integrated With Semiconductor Optical Amplifier

10-Gbit/s, 200 km duobinary SMF transmission using a full C-band tunable DFB laser array co-packaged with InP Mach-Zehnder modulator

10-Gbit/s optical duobinary transmission using lossless InP n-p-i-n Mach-Zehnder modulator with semiconductor optical amplifier

1027 KUPFFER IMAGE BY CONTRAST-ENHANCED US WITH SONAZOID IS USEFUL FOR EVALUATING HYPOVASCULAR LIVER NODULES DEPICTED AS HYPOINTENSE IN THE HEPATOBILIARY PHASE OF GD-EOB-DTPA-ENHANCED MRI

1037 PREDICTING FACTORS OF LOCAL RECURRENCE AFTER CURATIVE PERCUTANEOUS RADIOFRECUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA

1038 DECREASE OF PLASMA VEGF LEVEL WITHIN 2 MONTHS AFTER SORAFENIB ADMINISTRATION PREDICTS TREATMENT EFFICACY AND PROGNOSIS IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

1041 OUTCOMES OF RADIOFREQUENCY ABLATION FOR HYPOVASCULAR HEPATOCELLULAR CARCINOMAS

1070 Regenerating islet-derived related protein 4 as candidate of a novel biomarker in castration-resistant prostate cancer patients

107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

111 - Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer

1111PRisk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer

1151 Gemcitabine plus paclitaxel as third-line chemotherapy: A feasible option for metastatic urothelial carcinoma patients

1251 Evaluation of pharmacokinetics and safety profiles between S-1 granule and S-1 capsule in patients with solid tumors

1252 POSTER First Report of the Safety, Tolerability, and Pharmacokinetics of Saracatinib (AZD0530) in Japanese Patients With Advanced Solid Tumours

127PA model based on a new inflammation-nutrition score and TNM stage for predicting overall survival of patients with colorectal cancer

13 POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND BENEFIT OF VIRAL ERADICATION BY PEG-INTERFRON/RIBAVIRIN TREATMENT

1347 A PROSPECTIVE STUDY ON THE CLINICAL IMPACT OF VIRAL ERADICATION AND IL-28B GENOTYPE ON PEG-INTERFERON AND RIBAVIRIN THERAPY AFTER CURATIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA

1419 POSTER Identification of a Protein Kinase Activity Based Biomarker Fingerprint to Predict Response to Sunitinib, Sorafenib and Pazopanib in Scirrhous Gastric Cancer Cell Lines

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

1451P Neoadjuvant and adjuvant pembrolizumab (pembro) + chemotherapy (chemo) for locally advanced gastric or gastroesophageal junction (G/GEJ) cancer: Patient-reported outcomes (PROs) from the phase III KEYNOTE-585 study

Suchergebnisse filtern